Clinical Trials in Tennessee

Showing 12941-12960 of 20,239 trials

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

NCT02285920

The SPin-D Trial is a phase II randomized, double-blind, placebo-controlled, multi-center study of spironolactone (SPL) for patients with hemodialysis-dependent end-stage renal disease.

End-Stage Renal Disease

University of Pennsylvania129 participantsStarted Nov 2014

Washington D.C., District of Columbia, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 392 miles

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

NCT02237950

A double-blind, phase 3 study to determine the efficacy of SPL7013 Gel when administered on alternate days for 16 weeks, compared to placebo gel in preventing the recurrence of BV in women with a history of recurrent BV.

Bacterial Vaginosis

Starpharma Pty Ltd586 participantsStarted Oct 2014

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Little Rock, Arkansas, United States +42 more locations

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Find Trials by Condition in Tennessee

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Study Assessing Double-masked Uveitis Treatment

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Clinical Study of WT2725 in Patients With Advanced Malignancies

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Post Market Evaluation of Aer-O-Scope Visualization